Etodolac and Capecitabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etodolac (etodolac) and Capecitabine (capecitabine). Common drug interactions include neuropathy peripheral among females and apnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Etodolac and Capecitabine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Capecitabine?

Capecitabine has active ingredients of capecitabine. eHealthMe is studying from 59,495 Capecitabine users. Check the latest studies of Capecitabine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 03, 2026

11 people who take Etodolac and Capecitabine together, and have interactions are studied.

Etodolac and Capecitabine drug interactions.

What are the common drug interactions of Etodolac and Capecitabine, by gender? *:

female:

Neuropathy peripheral (surface nerve damage)
Surgery
Abscess (pus)
Arthralgia (joint pain)
Blood glucose decreased
Death
Decreased activity
Diarrhoea
Disease progression
Dry skin

male:

Apnoea (suspension of external breathing)
Cardiac arrest
Snoring
Sweating increased (excess sweating)
Tremor (trembling or shaking movements in one or more parts of your body)
Ventricular arrhythmia (problem with the rate or rhythm of the heartbeat)
Vomiting

What are the common drug interactions of Etodolac and Capecitabine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Vomiting
Apnoea (suspension of external breathing)
Cardiac arrest
Diarrhoea
Dry skin
Hypoaesthesia (reduced sense of touch or sensation)
Nausea (feeling of having an urge to vomit)
Onychoclasis (breaking of the nails)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Skin fissures (a crack in the skin)

60+:

Atypical femur fracture
Abscess (pus)
Arthralgia (joint pain)
Blood glucose decreased
Decreased activity
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Disease progression
Dizziness
Hypotension (abnormally low blood pressure)
Neuropathy peripheral (surface nerve damage)

What are the existing conditions these people have? *

Breast Cancer: 7 people, 63.64%
Neoplasm Malignant (cancer tumour): 2 people, 18.18%
Dyslipidaemia (abnormal amount of lipids): 2 people, 18.18%
Metastases To Bone (cancer spreads to bone): 1 person, 9.09%
Breast Cancer Female: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and Capecitabine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously